184 related articles for article (PubMed ID: 32624291)
1. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma.
Moekotte AL; van Roessel S; Malleo G; Rajak R; Ecker BL; Fontana M; Han HS; Rabie M; Roberts KJ; Khalil K; White SA; Robinson S; Halimi A; Zarantonello L; Fusai GK; Gradinariu G; Alseidi A; Bonds M; Dreyer S; Jamieson NB; Mowbray N; Al-Sarireh B; Mavroeidis VK; Soonawalla Z; Napoli N; Boggi U; Kent TS; Fisher WE; Tang CN; Bolm L; House MG; Dillhoff ME; Behrman SW; Nakamura M; Ball CG; Berger AC; Christein JD; Zureikat AH; Salem RR; Vollmer CM; Salvia R; Besselink MG; Abu Hilal M; ; Aljarrah R; Barrows C; Cagigas MN; Lai ECH; Wellner U; Aversa J; Dickson PV; Ohtsuka T; Dixon E; Zheng R; Kowalski S; Freedman-Weiss M
Eur J Surg Oncol; 2020 Sep; 46(9):1717-1726. PubMed ID: 32624291
[TBL] [Abstract][Full Text] [Related]
2. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
[TBL] [Abstract][Full Text] [Related]
3. International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.
van Roessel S; Strijker M; Steyerberg EW; Groen JV; Mieog JS; Groot VP; He J; De Pastena M; Marchegiani G; Bassi C; Suhool A; Jang JY; Busch OR; Halimi A; Zarantonello L; Groot Koerkamp B; Samra JS; Mittal A; Gill AJ; Bolm L; van Eijck CH; Abu Hilal M; Del Chiaro M; Keck T; Alseidi A; Wolfgang CL; Malleo G; Besselink MG
Eur J Surg Oncol; 2020 May; 46(5):796-803. PubMed ID: 31924432
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma.
Schneider C; Sodergren MH; Pencavel T; Soggiu F; Bhogal RH; Khan AZ
Surg Oncol; 2020 Dec; 35():211-217. PubMed ID: 32911213
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
[TBL] [Abstract][Full Text] [Related]
9. Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.
Nassour I; Christie A; Choti MA; Mansour JC; Minter RM; Polanco PM; Augustine MM; Porembka MR; Xie XJ; Wang SC
J Gastrointest Surg; 2018 May; 22(5):792-801. PubMed ID: 29546687
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
[TBL] [Abstract][Full Text] [Related]
11. Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network models.
Wu Y; Li Q; Cai Z; Zhang Y; Qiu Y; Yang N; Song T; Li S; Lou J; Li J; Mao X; Chen C; Zhang D; Si S; Geng Z; Tang Z
Eur J Surg Oncol; 2020 Nov; 46(11):2106-2113. PubMed ID: 32807616
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and benefits of adjuvant therapy for ampullary cancer following pancreatoduodenectomy: A systematic review and meta-analysis.
Zhou YM; Liao S; Wei YZ; Wang SJ
Asian J Surg; 2020 Dec; 43(12):1133-1141. PubMed ID: 32249101
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
Moekotte AL; Lof S; Van Roessel S; Fontana M; Dreyer S; Shablak A; Casciani F; Mavroeidis VK; Robinson S; Khalil K; Gradinariu G; Mowbray N; Al-Sarireh B; Fusai GK; Roberts K; White S; Soonawalla Z; Jamieson NB; Salvia R; Besselink MG; Abu Hilal M
Ann Surg; 2020 Dec; 272(6):1086-1093. PubMed ID: 30628913
[TBL] [Abstract][Full Text] [Related]
14. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
Gold JS; Tang LH; Gönen M; Coit DG; Brennan MF; Allen PJ
Ann Surg Oncol; 2007 Nov; 14(11):3159-67. PubMed ID: 17680313
[TBL] [Abstract][Full Text] [Related]
15. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy.
Sakai A; Tsujimae M; Masuda A; Iemoto T; Ashina S; Yamakawa K; Tanaka T; Tanaka S; Yamada Y; Nakano R; Sato Y; Kurosawa M; Ikegawa T; Fujigaki S; Kobayashi T; Shiomi H; Arisaka Y; Itoh T; Kodama Y
World J Gastroenterol; 2019 Mar; 25(11):1387-1397. PubMed ID: 30918431
[TBL] [Abstract][Full Text] [Related]
19. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
20. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]